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Backgrounds/Aims: Minimally invasive surgery is a widely accepted approach in hepatobiliary surgery and choledochal 
cyst excision has also been performed by minimally invasive methods, including laparoscopic and robotic approaches. 
However, only a few studies have compared laparoscopic and robotic surgery. Therefore, we performed a comparative 
study between two groups, including cost aspects. Methods: We retrospectively analyzed minimally invasive chol-
edochal cyst excision at Severance Hospital in Seoul, South Korea from January 2005 to December 2018. A total 
of 39 patients that underwent minimally invasive choledochal cyst excision were identified. The 23 patients (58.9%) 
and 16 patients (41.1%) were enrolled in laparoscopic and robotic approach, respectively. We compared the patient’s 
characteristics, and perioperative outcomes between laparoscopic and robotic surgery groups. Results: A comparative 
analysis between the two groups showed no differences in preoperative clinical characteristics. There were no sig-
nificant differences in operative time, estimated blood loss, and postoperative complications, including biliary 
complication. The preoperative ASA score (p=0.021) and hospital stays (p=0.011) were the only clinical variables that 
differed between the two groups. All of the variables included in the cost analysis showed statistically significant differ-
ences (total hospital charge: p=0.035, patient’s bill: p≤0.001, operation: p=0.002, anesthesia: p=0.001, postoperative 
management: p=0.001). Conclusions: The overall clinical outcomes between the laparoscopic and robotic approach 
to choledochal cyst were comparable. The surgical approach should be balanced based on the surgeons’ skill, patients’ 
general condition, disease extent, and economic status. (Ann Hepatobiliary Pancreat Surg 2021;25:71-77)
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INTRODUCTION
Choledochal cysts are a rare cystic disease in the biliary 
tract. Most cases develop in children under 10 years of 
age and there is a higher incidence in the Asian pop-
ulation than in other ethnicities.1 In the past, only enteric 
drainage was performed for choledochal cysts, leading to 
recurrent cholangitis due to biliary stasis. The malignant 
potential of choledochal cysts, such as cholangiocarcinoma 
and gallbladder cancer which have been reported in 5% 
to 10% of patients with choledochal cysts,2 is concerning. 
Therefore, surgical resection of the cyst and cholecystectomy 
with appropriate reconstruction for biliary drainage using 
a bilo-enteric anastomosis is typically performed today.3-5
Minimally invasive surgery is more widely accepted in 
hepatobiliary surgery. Choledochal cyst excision has also 
been performed by minimally invasive methods, including 
laparoscopic and robotic approaches.6-10 Furthermore, sev-
eral studies have compared clinicopathologic outcomes 
between laparoscopic and robotic surgeries and have shown 
the superiority and feasibility of robotic surgery.11,12 However, 
the number of reported studies on minimally invasive chole-
dochal cyst excisions is not sufficient, especially in regard 
to cost efficiency.
Therefore, we investigated a total of 39 cases of mini-
mally invasive choledochal cyst excision and compared 
short-term outcomes between laparoscopic and robotic ap-
proaches, including cost aspects.
72  Ann Hepatobiliary Pancreat Surg Vol. 25, No. 1, February 2021 www.ahbps.org
Fig. 1. Minimally invasive ap-
proach to treat choledochal cyst. 
Laparoscopic isolation (A), and 
resection of choledochal cyst (B). 
Note subsequent laparoscopic 
choledochojejunostomy (C) and 
robotic reconstruction (D). B, 
bile duct; CC, choledochal cyst; 
D, duodenum; J, jejunum.
MATERIALS AND METHODS
Data collection
The medical records of the patients who underwent sur-
gery for choledochal cysts in the Severance Hospital in 
Seoul, South Korea from January 2005 to December 2018 
were retrospectively reviewed. Patients who needed com-
bined hepatectomy were excluded. Perioperative clinical 
parameters such as age, sex, body mass index (BMI), 
chief complaint, presence of anomalous pancreaticobiliary 
ductal union (APBDU), Todani classification, American 
Society of Anesthesiologist (ASA) score, preoperative car-
cinoembryonic antigen (CEA), Carbohydrate antigen (CA) 
19-9, total bilirubin, operation time, estimated blood loss, 
retrieved lymph nodes, medical cost, hospital stays, types 
of complication, postoperative intervention and period of 
surgery were collected. Biliary stricture was defined as 
follow-up abdomino-pelvic computed tomography (APCT) 
findings which showed intrahepatic duct dilatation and a 
need for interventional radiological management, such as 
percutaneous transhepatic biliary drainage. Biliary leakage 
was also diagnosed with APCT scans and some cases 
needed percutaneous drainage. Laboratory tests were also 
used to diagnose biliary complications. 
Preoperative magnetic resonance cholangiopancreatog-
raphy and APCT were performed on all included cases 
to evaluate the clinical stage and type of choledochal cyst. 
Patients were followed-up on an outpatient basis. APCT 
and laboratory tests, including for tumor markers were 
performed within 6 months after surgery to evaluate early 
and delayed postoperative complications.
Surgical technique
Brief minimally invasive surgical procedures are showed 
in Fig. 1. Using a robotic surgical system is preferred for 
an accurate and gentle anastomosis, because it allows for 
stable handling and suturing. However, the surgical instru-
ments for excision in robotic surgical systems are limited. 
Based on the assessment that laparoscopic resection is 
more appropriate, robotic cases were performed by a hy-
brid procedure, with the exception of the first few cases. 
Selection of the surgical approach was determined based 
on the surgeon’s preference and the patient’s financial 
status. A case of robot-assisted excision of choledochal 
cysts, hepaticojejunostomy, and extracorporeal Roux-en-y 
anastomosis was reported previously and the detailed sur-
gical technique was described in that report.9
Cost analysis
The total hospital charges were classified into four cate-
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Table 1. Incidence of surgery over time according to surgical approach
 2005-2008 2009-2013 2014-2018 p
Laparoscopic (n=23) 1 (11.1%) 4 (40.0%) 18 (90.0%) ＜0.001
Robotic (n=16) 8 (88.9%) 6 (60.0%) 2 (10.0%)







  Male 3 (13.0%) 3 (18.7%)
  Female 20 (87.0%) 13 (81.3%)
Age (years) 34.3±11.2 37.0±10.7 0.462
BMI (kg/m2) 23.0±3.0 21.4±2.4 0.098
Chief complaint 0.987
  No 13 (56.5%) 9 (56.3%)
  Pain 10 (43.5%) 7 (43.7%)
Past medical history 0.100
  None 22 (95.7%) 13 (81.3%)
  Diabetes 0 (0.0%) 2 (12.5%)
  Hepatitis 0 (0.0%) 1 (6.3%)
  Multiple combined 1 (4.3%) 0 (0.0%)
ASA score 0.021
  1 15 (65.2 %) 16 (100.0%)
  2 6 (26.1%) 0 (0.0%)
  3 2 (8.7%) 0 (0.0%)
Todani classification 0.398
  I 22 (95.7%) 16 (100.0%)
  II 1 (4.3%) 0 (0.0%)












gories: total hospital charge, patient’s bill, operative charge, 
anesthesia charge, and charges from postoperative man-
agement. Considering that the reimbursement of hospital 
charges is about 80% by the National Health Insurance 
Corporation (NHIC), the actual patient’s bill was classi-
fied separately, and was defined by the sum of 20% of 
the insured charge and 100% the of non-insured charge. 
The operative charge included the surgery fee and cost 
of instruments and supplies for the surgery. The anes-
thesia charge included a fee for anesthesia, medications 
for induction and maintenance of anesthesia. In some cas-
es, intravenous patient-controlled analgesia was applied 
and charged as a non-insured anesthesia charge. Charges 
for postoperative management included any medications 
for postoperative care, imaging studies for follow-up and 
surveillance of postoperative complications and laboratory 
tests. All costs were converted to US dollars based on the 
exchange rate of May 2019 ($1=₩1,197).
Statistical analysis
Continuous variables were analyzed with a student t-test 
or Mann-Whitney U test in the case of non-normal dis-
tribution. Categorical variables were analyzed by chi-square 
test or Fisher’s exact test. Operation time was also analyzed 
and compared by simple linear regression analysis. The 
data were analyzed by SPSS (Version 21, IBM, USA).
RESULTS
Chronological changes in the surgical approach 
to choledochal cysts
A total of 39 patients that underwent minimally in-
vasive choledochal cyst excision were identified. The lap-
aroscopic approach was performed in 23 patients (58.9%), 
and the robotic approach was performed in 16 patients 
(41.1%). In the early period of applying the minimally in-
vasive approach to choledochal cysts, robotic surgery was 
performed more frequently than laparoscopic surgery. 
Over time, with the experiences of laparoscopic surgery 
increasing, the incidence of laparoscopic surgery increased 
beyond robotic surgery (Table 1).
Preoperative clinical characteristics
The general characteristics of patients are presented in 
Table 2. There were no significant differences in sex, age, 
chief complaint, and past medical history. The preopera-
tive BMI was also similar between the two groups (23.0± 
3.0 vs. 21.4±2.4, p=0.098). 
The preoperative clinical variables are shown in Table 
2. There were no significant general clinical differences 
between the two groups. According to Todani classifica-
tion, Type I was most common in both groups and only 
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  No 21 (91.3%) 11 (68.8%)
  Yes 2 (8.7%) 5 (31.3%)
Biliary stricture 0.631
  No 21 (91.3%) 13 (81.3%)
  Yes 2 (8.7%) 3 (18.8%)







Retrieved lymph node 1.2±2.6 0.1±0.3 0.114
Complications 0.069
  None 16 (69.6%) 8 (50.0%)
  Biliary complication 6 (26.1%) 7 (43.7%)
  Roux limb 
  obstruction 
1 (4.3%) 0 (0.0%)
  Port site hernia 0 (0.0%)  1 (6.3%)
Postoperative interventions 0.783
  None 20 (87.0%) 13 (81.3%)
  PTBD 2 (8.7%) 3 (18.8%)
  Pigtail insertion 1 (4.3%) 0 (0.0%)







Total hospital charge 6,568±1,047 7,331±720 0.035
  Patient’s bill 2,626±632 6,578±1,081 ＜0.001
  Operation 4810±954 5,781±845 0.002
  Anesthesia 612±138 788±154 0.001
  Postoperative 
  management 
1,098±260 716±264 0.001
Fig. 2. Time-dependent biliary stricture-free probability.
1 case belonging to the robotic group was classified as 
type II. Diameter of bile duct measured at upper resection 
margin was similar between two groups (mm, 9.8±1.9 vs. 
11.5±4.3, p=0.099). The mean preoperative CEA (ng/ml, 
1.3±1.7 vs. 1.4±1.1, p=0.363), CA 19-9 (U/ml, 11.2±13.3 
vs. 13.4±12.0, p=0.358) and total bilirubin (mg/dl, 0.6±0.3 
vs. 0.7±0.4, p=0.366) were also similar between the two 
groups. The ASA score was the only variable that showed 
a statistically significant difference in the preoperative 
findings (p=0.021).
Intraoperative and postoperative outcome
Several intraoperative findings are presented in Table 
3. No significant difference in the average operation time 
was observed between the two groups (333.6±60.9 vs. 
362.9±86.6, p=0.221). The mean estimated blood loss 
(ml) was higher in the robotic surgery group but not sig-
nificantly different compared to the laparoscopic group 
(128.3±159.1 vs. 186.9±214.7, p=0.746). The number of 
retrieved lymph nodes is minimal in both groups (1.2±2.6 
vs. 0.1±0.3, p=0.114). Some perioperative findings show-
ing postoperative outcomes are presented in Table 3. 
Hospital stays (days) were significantly longer in the ro-
botic surgery group than in the laparoscopic surgery group 
(11.4±6.3 vs. 14.7±5.6, p=0.011). The incidence of post-
operative complications was higher in the robotic surgery 
group. Table 4 shows biliary complication between two 
groups. Biliary leakage was observed more frequently in 
the robotic surgery group than in the laparoscopic surgery 
group, but the finding was not statistically significant 
(8.7% vs. 31.3%, p=0.101). Biliary stricture was also more 
common in the robotic surgery group (8.7% vs. 18.8%, 
p=0.631). Biliary stricture free probability is showed in 
Fig. 2 and there is no statistical difference.
Cost analysis
The total hospital charge was higher in the robotic 
group ($6,568±1,047 vs. $7,331±720, p=0.035) (Table 5). 
The difference in the actual patient’s bill was also remark-
ably higher in the robotic group ($2,626±632 vs. $6,578± 
1,081, p＜0.001). The anesthesia charge was higher too 
in the robotic group ($612±138 vs. $788±154, p=0.001). 
But the charge from postoperative management was high-
er in the laparoscopic group compared with the robotic 
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group ($1,098±260 vs. $716±264, p=0.001).
DISCUSSION
As minimally invasive techniques became popular in 
oncologic surgery, the cases of minimally invasive chol-
edochal cyst excision increased since the approach was 
first reported in 1995 by Farello et al.13 Our institution 
has been performing minimally invasive choledochal cyst 
excision since 2005 and a total of 39 cases which con-
sisted of 23 laparoscopic cases and 16 robotic cases, have 
been performed up until December 2018. 
There was no significant difference in the patient’s 
characteristics. Perioperative outcomes were also similar, 
except for hospital stays which was longer in the robotic 
group (11.4±6.3 vs. 14.7±5.6, p=0.011). Most patients with 
robotic surgery had private insurance, which led to a de-
lay in discharge from the hospital, and this factor seems 
to be associated with longer hospital stays. In addition, 
a higher rate of complications in the robotic surgery group 
required additional time in postoperative management. 
However, when referring to other studies, variables like 
postoperative complications and data for comparing func-
tional recovery rather than length of hospital stay can be 
more appropriate to evaluate efficacy of minimally in-
vasive surgery.14-16
As mentioned before, the rate of biliary complications 
for containing bile leakage and biliary stricture were high-
er in the robotic surgery group. This result showed contra-
dictory view from other papers dealing with minimally in-
vasive choledochal cyst excision.11,12 But there was possi-
bility of bias in different biliary stricture rate between two 
groups. It might be associated with surgeon’s learning 
curve and observation period. Considering that some time 
(median 131 month) is needed for development of biliary 
stricture, the minimally invasive surgery for choledochal 
cyst excision was almost done with robotic approach in 
early period of time. Therefore, higher prevalence of bili-
ary stricture in robotic surgery group was also explained 
by other factors as mentioned above. Further follow up 
study is mandatory.
The total hospital charge was higher in the robotic 
group compared to the laparoscopic group, especially re-
gard to operation charge. Because the cost for robotic sur-
gery is not included in the insurance charge, the cost for 
robotic surgery is not reimbursed by the NHIS in South 
Korea, therefore, the patient’s burden for the hospital 
charge was significantly higher in the robotic group. So, 
the presence of private insurance affected the patient’s 
choice of surgical methods, laparoscopic or robotic. Even 
though longer hospital stays were observed in the robotic 
surgery group, the cost from postoperative management 
was higher in the laparoscopic surgery group. This is like-
ly attributable to the increase in the amount of routinely 
used drugs, combined with the increase in the rate of lapa-
roscopic surgery over time.
Robotic surgery was introduced in the late 1990s and 
was initially confined to several medical areas, including 
urology and gynecology. As refinement of the technology, 
such as better image quality, and reduced charges for sur-
gery, robotic surgery has expanded into general surgery 
fields such as hepatobiliary, colorectal, endocrine surgery 
and even breast surgery.17-20 Robotic surgery has been de-
veloped to overcome disadvantages and limitations of lap-
aroscopic surgery such as limited degree of motion, com-
prised dexterity, the fulcrum effect and two-dimensional 
visualization. Despite the advantages of robotic surgery, 
compared with laparoscopic surgery, there are several dis-
advantages associated with robotic surgery. The high cost 
of the operation and set up is a major factor that prevent 
surgeons from choosing robotic surgery.21,22 In terms of 
oncologic safety, there is limited supporting clinical evi-
dence, therefore factors such as a shortage of long-term 
clinical outcomes is a concern for robotic surgery. The da 
VinciⓇ Surgical System which is the most widely used 
robot surgical system in our institution is comprised of 
three components: The Surgeon’s console, Patient’s cart, 
and the Vision cart. Not only does it require a specific 
amount of space, but the system also requires skilled extra 
staff to assist with docking the system to the patient. 
Therefore, an additional charge and time were needed to 
satisfy all these factors. 
At our institution, minimally invasive choledochal cyst 
excision was initially performed with the robotic approach. 
Based on those experiences, laparoscopic surgical skills 
were improved and other hepatobiliary surgeries such as 
hepatectomy and pancreatectomy have been performed 
more recently with the laparoscopy. As a result, in consid-
eration of the general conditions and economic status of 
patients, performance of laparoscopic choledochal cyst ex-
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cision also increased, rather than unconditionally adopting 
robotic surgery.
Our study has several limitations. The first is that some 
surgical procedures in the same group were not performed 
in the same way. For example, among 23 cases of laparo-
scopic surgery, 16 cases were performed for the Roux-en-y 
hepaticojejunostomy by the intracorporeal method but in 
the remaining 7 cases, they were performed extracorporeally. 
The robotic surgery group also did not have the same 
Roux-en-y hepaticojejunostomy method (3 intracorporeally 
vs. 13 extracorporeally). This is associated with the se-
lection of the surgical approach (hybrid or total robotic 
approach).
The second limitation is that this study was designed 
retrospectively; thus, several medical records, such as de-
tailed postoperative complications related to this study 
could not be verified. The third is that there was a short-
age of cases because of the single institution in the study. 
Choledochal cysts are more commonly diagnosed in chil-
dren and more of the surgeries were actually performed 
in children.1 However, the youngest person in this study 
was 15 years old and most people were over 20 years old. 
In conclusion, the overall statistical outcomes between 
laparoscopic and robotic choledochal cyst excision ap-
proaches were comparable, and the selection of surgical 
method should be decided in consideration of variety fac-
tors including const aspect.
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